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Introduction
The fumonisins are known as important mycotoxins 
produced mostly by several Fusarium species which are 
found mainly in maize and its products all over the 
world. Because of the similarity between fumonisins 
and the sphingoid bases sphinganine (Sa) and sphingo-
sine (So), fumonisin disrupts the sphingolipid metabo-
lism and impacts on animal health. Pigs are high sensi-
tive species to fumonisin B1 (FB1), the lowest observed 
adverse effect level (LOAEL) of fumonisin is 200 µg/kg 
b.w. per day (EFSA, 2005). It is very important to know 
the activities of fumonisin from the digestion on the 
cell systems. However, only a few studies have been 
conducted to determine fumonisin activities in the 
gastrointestinal tract of pigs, especially interaction 
between fumonisin and gut microbiota. Only one 
report showed the fumonisin was metabolised by the 
caecal micro organism (Fodor et al., 2007) while there 
was no complete research about the effect of fumoni-
sins on the intestinal microbiota in pigs. Some in vivo, 
not in vitro studies were carried out to estimate the 
impact of fumonisin on individual microbial species 
such as Escherichia coli and Salmonella sp. According 
to the results, intestinal colonization of pathogenic 
E. coli strain was significantly increased when pigs 
were treated with 0.5 mg of FB1/kg of body weight for 
7  days (Oswald et al., 2003) while no change of Sal­
monella enterica growth was presented in pig intestine 
with the moderate dose of fumonisin (8.6 mg FB1 and 
3.2 mg FB2 per kilogram feeding intake), it transiently 
affected the digestive microbiota balance (Burel et al., 
2013). It is essential to have more information about 
the impact of fumonisin mycotoxin on gastrointestinal 
microbiota in pigs. The gut microbiota balance should 
be concerned as a crucial factor keeping body health. 
From the gut microbiota ecosystem point of view, 
it is good to understand the activities of all kinds of 
bacteria rather than one or few particular types of 
them when treated with fumonisins. In the presented 
in vitro study, we investigated the interaction between 
FB1 and caecal microorganism in pigs i.) to seek signs 
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A b s t r a c t
The caecal chyme of pigs was incubated anaerobically in McDougall buffer with and without fumonisin B1 (5 µg/ml) for 0, 24 and 48 h. The 
plate count agar technique was applied for enumerating the amount of bacteria including aerobic, anaerobic bacteria, coliform, Escherichia 
coli and Lactobacillus sp. The quantitative polymerase chain reaction was also performed to estimate the number of copies of the total 
bacteria, Lactobacillus, Bacteroides and Prevotella. No significant differences in the amount of bacterial groups between the experimental 
(buffer, chyme, and fumonisin B1) and control 1 groups (buffer + chyme) were observed in both methods. Fumonisin B1 and hydrolysed 
fumonisin B1 concentration were analysed by liquid chromatograghy – mass spectrometry. There was no significant difference in FB1 
concentration between the experimental and the control 2 group (buffer and fumonisin B1) at 0 h incubation, 5.185 ± 0.174 µg/ml com-
pared with 6.433 ± 0.076 µg/ml. Fumonisin B1 concentration in the experimental group was reduced to 4.080 ± 0.065 µg/ml at 24 h and to 
2.747 ± 0.548 µg/ml at 48 h incubation and was significantly less than that of in the control group. Hydrolysed fumonisin B1 was detected after 
24 h incubation (0.012 ± 0 µg/ml). At 48 h incubation time, hydrolysed fumonisin B1 concentration was doubled to 0.024 ± 0.004 µg/ml. These 
results indicate that fumonisin B1 can be metabolised by caecal microbiota in pigs though the number of studied bacteria did not change.
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of biological effect on FB1 induced by gut microbiota 
and ii.) to determine the impact of FB1 on the growth 
of pig caecal bacteria.
Experimental
Materials and Methods
Sampling and processing. Samples of caecal con-
tent were collected from adult pigs (n = 2; Hungarian 
large white race) right after slaughtering from a slaugh-
ter house and transferred into sterile bottles. The bottles 
were put in anaerobic plastic bags with Anaerocult gas 
generator (Merck, Darmstadt, Germany). The pre-incu-
bated (24 h/37°C/anaerobic) McDougall buffer solution 
(9.8 g NaHCO3, 3.7 g anhydrous Na2HPO4, 0.57 g KCl, 
0.47 g NaCl, 0.12 g MgSO4 . 7H2O, 0.04 g CaCl2 and 
1000 ml aquadest; pH 8.3) were prepared to homo ge-
nise samples and make the solution for control groups.
The experiment was designed to 3 groups as shown 
in Table I. Two control groups were set up. The first 
controls contained buffer and chyme, while the second 
controls were prepared including buffer and FB1. 
Caecal chyme was homogenised and divided into 
the first control and experimental groups. An aliquot of 
3.33 g of caecal chyme was suspended in pre-incubated 
McDougal buffer tubes (experimental and the first con-
trol group). After a pre-incubation for four hours at 
37°C, FB1 (50 μg/g; Sigma-Aldrich, Darmstadt, Ger-
many) was added to each tube (experimental and the 
second control groups) to get a final concentration of 
5 µg/ml. Samples were taken at 0, 24 and 48 h of anaero-
bic incubation for determination of bacterial numbers 
and FB1 concentration.
Media and enumeration methods. The plate count 
technique on selected media was applied for deter-
mining the amount of bacteria. Approximately 1 g of 
post-incubated sample was collected and subsequently 
homogenised with 9 ml of peptone salt solution. Then 
the 10-folds series dilution was conducted from 10–1 to 
10–8. An aliquot (100 µl) was pipetted and add on the 
surface of each respective selected agar to culture bac-
teria. Five groups of bacteria were enumerated includ-
ing aerobic bacteria, anaerobic bacteria, coliform, E. coli 
and Lactobacillus sp. The aerobic and anaerobic bacteria 
were cultured in commercial blood agar (BA; Bak-Teszt 
Ltd., Budapest, Hungary). Coliform and E. coli popu-
lation were estimated on ChromoBio Coliform Agar 
(BioLab). The amount of Lactobacillus sp. was deter-
mined by using MRS agar (BioLab).
The colony forming units/g (CFU/g) were calculated 
using the formula:
N = ΣC/Vx1, 1xd
ΣC is the sum of the colonies counted on the two dishes 
retained from two successive dilutions, at least one 
of which contains a minimum of 10 colonies
V is the volume of inoculums placed in each dish, in 
millilitres
d is the dilution corresponding to the first dilution 
retained
DNA extraction and QPCR. The DNA extraction 
was carried out with approximately 200 mg of the fro-
zen caecal sample using the QIAamp®DNA Stool Mini 
Kit according to the manufacturer’s instructions. DNA 
concentrations were measured using Smart Spec Plus 
Spectrophotometer (Maestrogen Inc.) based on the 
ratio of absorbance at 260 nm and 280 nm. 
The standard curve was created by dilution series 
of purified PCR products for Lactobacillus sp. while 
the dilution series of plasmid concentration were used 
to prepare the standard curve for total bacteria, Bac­
teroides and Prevotella.
The quantity of total bacteria, Lactobacillus sp., Bac­
teroides and Prevotella, were determined by Quantita-
tive PCR (QPCR) using SYBR Green. The primers for 
investigated bacterial groups were selected based on 
previous literature (Table II). QPCR was conducted in 
a 25 µl/tube reaction mixture containing 12.5 µl Brillant 
II SYBR QPCR Low Rox Master Mix (Agilent Techno-
logies, CA, USA), 0.2 µM of each primer, 10.5 µl sterile 
DEPC treated distilled water and 1 µl of DNA extract. 
The PCR program consisted of 10 min at 95°C, 40 cycles 
of 30 sec at 95°C, 1 min at 60°C. All samples were meas-
ured in triplicates. The bacterial content of the sam-
 0 h 4 4 4
24 h 4 4 4
48 h 4 4 4
Description 12 × 3,33 g chyme 12 × 3,33 g chyme 12 × 9 ml buffer
 12 × 5,67 ml buffer 12 × 5,67 ml buffer 12 × 1 ml 50 µg/g FB1
 12 × 1 ml 50 µg/g FB1 1 ml H2O
Table I
Experimental design.
Incubation
(h)/treatment
Experimental group
(Buffer+Chyme+FB1)
Control 1 group
(Buffer+Chyme)
Control 2 group
(Buffer+FB1)
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ples was calculated by comparison with the standard 
curve derived from dilution series. The obtained copy 
numbers of the samples were adjusted to one gram 
of caecum contents.
Mycotoxin extraction and analysis. For FB1 extrac-
tion, the post-incubated samples from the experimental 
group and the control 2 group (Table I) were diluted 
2-fold (7 ml sample and 7 ml distilled water) and cen-
trifuged for 5 minutes (3000 rpm). The supernatant was 
used for FB1 extraction followed by the modified pro-
tocol of Sep-Pak C18 cartridges (Waters Co., Milford, 
MA, USA) (Szabó-Fodor et al., 2014). The precondi-
tioning column was conducted with 2 ml of methanol 
then 2 ml of distilled water. The diluted chyme (2 ml) 
was subsequently loaded onto the columns then washed 
again with 2 ml of distilled water. The elution of FB1 was 
completed by 2 ml of water/acetonitrile mixture, 1:1 v/v.
Liquid chromatography and mass spectrometry 
(LC-MS) analysis were performed by a Shimadzu 
Pro minence UFLC separation system equipped  with 
an LC-MS-2020 single quadrupole (ultra-fast) liquid 
chromatograph mass spectrometer (Shimadzu, Kyoto, 
Japan) with the electrospray source. Optimised mass 
spectra were obtained with an interface voltage of 4.5 kV, 
a detector voltage of 1.05 kV in negative mode, 1.25 kV 
in positive mode. Samples were analysed on a Pheno-
menex Kinetex 2.6 μ X-C18 column (100 mm × 2.1 mm). 
The column temperature was set to 50°C; the flow rate 
was 0.3 ml/minute. The gradient elution was performed 
using LC-MS grade water (VWR Hungary, Debrecen) 
(eluent A) and methanol (eluent B), both acidified with 
0.1% acetic acid. One µl of each samples were analysed 
with a gradient: (0 min) 5% B, (3 min) 60% B, (8 min) 
100% B, followed by a holding time of 3 min at 100% 
eluent B and 3 min column re-equilibration at eluent 
A. Romer Mix 3 (containing FB1 + FB2 at 50 mg/l) and 
HFB1 primary stock solution used as reference. MS 
parameters: source block temperature 90°C; desolva-
tion temperature 250°C; heat block temperature 200°C; 
drying gas flow 15.0 l/min. Detection was performed 
using selected ion monitoring (SIM) mode. 
The efficiency of FB1 conversion to fully hydrolysed 
FB1 (HFB1) was calculated on the basis of the mole-
cular weight of the compounds (FB1: 721 g/mol; HFB1: 
405 g/mol) and described as below:
Hydrolysed fumonisin B1 (mol/g) × 721 g/mol
405 g/mol x Fumonisin B1 (mol/g)
Statistical analysis. The R i386 3.1.2 program was 
applied for statistical analyses. The comparative means 
were performed by Independent Samples t-Test, one-
way ANOVA with Tukey post-hoc test and non-para-
metric Kruskal-Wallis test if the normal distribution 
was not presented.
Results and Discussion
Effect of microflora on fumonisin B1. At 0 h incu-
bation time, no significant FB1 concentration difference 
between the experimental group (buffer, caecal content, 
FB1) and control 2 group (buffer, FB1) was observed; 
5.185 ± 0.175 µg/ml compared with 6.433 ± 0.076 µg/ml, 
respectively. FB1 concentration in experimental groups 
was significant lower than control-2 group after 24 h 
and 48 h incubation period, 4.080 ± 0.065 µg/ml and 
2.747 ± 0.548 µg/ml compared to 6,338 ± 0,108 µg/
ml and 4.587 ± 0.085 µg/ml, respectively. FB1 concen-
tration also decreased during incubation time in the 
expe rimental group (Fig. 1). HFB1 concentration has 
Total bacteria Fwd: GCAGGCCTAACACATGCAAGTC 292 Castillo et al., 2006; Marchesi et al., 1998
 Rev: CTGCTGCCTCCCGTAGGAGT  Amann et al., 1995
Bacteroides and Prevotella Fwd: GAAGGTCCCCCACATTG 418 Kim, 2011
 Rev: CAATCGGAGTTCTTCGTG  Bartosch et al., 2004
Lactobacillus sp. Fwd: AGCAGTAGGGAATCTTCCA 340 Su et al., 2008; Walter et al., 2000
 Rev: CACCGCTACACATGGAG  Heilig et al., 2002
Table II
Oligonucleotide sequences used for QPCR in caecal samples from pigs.
Investigated group Oligonucleotide sequence (5’-3’) Ampliconlength (bp) Refs.
Fig. 1. Fumonisin B1 concentration in experimental groups
and control 2 groups during the incubation time.
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also been determined at different incubation times. Due 
to the appearance of main products of the metabolism 
(HFB1) only in the experimental group (Fig. 2), we can 
conclude that FB1 may be metabolised by microbiota in 
the caecum of the pig.
The capability of bacteria to influence fumoni-
sins was by Niderkorn et al. (2009) and Zoghi et al., 
(2014). Peptidoglycan, the component of bacterial cell 
wall, plays a crucial role in binding many mycotoxins 
including fumonisins. Lactobacillus sp. is the class of 
bacteria having a significant impact on fumonisins. The 
FB1 level in maize was decreased by lactic acid bacte-
rial activity after 3-day fermentation (Mokoena et al., 
2005). To determine the effect of the microorganism 
to fumonisins, most of the studies were conducted 
to estimate the impact of bacteria to fumonisin pro-
duced by Fusarium sp. such as binding or inhibition 
of fumonisin production while few of them were con-
cerned with fumonisin metabolism. The concentration 
of FB1 was reduced by Lactobacillus paracasie subsp. 
Paracasie after 20-day incubation (70.5 µl/ml compared 
with 300 µl/ml FB1 in the control group) and L. para­
casie subsp. Paracasie could inhibit FB1 production in 
a 10-day incubation period (Gomah and Zohri, 2014). 
Becker et al. (1997) reported that FB1 was not degraded 
by Enterococcus faecium while the binding of FB1 and 
FB2, up to 24 and 62%, respectively by Enterococcus sp. 
was determined (Niderkorn et al., 2007). 
In agreement with former results reported by Fodor 
et al. (2007), the conversion of FB1 to HFB1 was less 
than 1% where there was no change in the degree of 
the conversion of FB1 to aminopentol (fully hydrolysed 
FB1). In this study, conversion of FB1 to HFB1 increased 
significantly from 0.33% to 0.66% after 24 h and 48 h 
incubation time, respectively. Differences in the HFB1 
related results can be explained on the basis of the dif-
ferent bacterial ecosystem in the gut of experimental 
pigs. The various structures of gut microbiota may 
be derived from different diets, time of the sampling or 
individual enterotypes of the porcine gut microbiota 
(Pajarillo et al., 2014; Frese et al., 2015).
Effect of fumonisin B1 on caecal microbiota in 
pigs. Five groups of bacteria were quantitatively deter-
mined by microbial culturing including aerobic bacte-
ria, anaerobic bacteria, coliform, E. coli and Lactobacil­
lus sp. There was no significant difference in the groups 
without FB1 during the period of the incubation time 
except the anaerobic bacteria group. The log10 number 
of anaerobic bacteria decreased from 9.046 ± 0.036 (0 h 
incubation) to 8.389 ± 0.143 (48 h incubation) (Table III). 
In the caecal bacteria with FB1 groups, reduction of 
the log 10 number of anaerobic bacteria were identified, 
from 9.017 ± 0.054 to 8.340 ± 0.082, while there was an 
increase in Lactobacillus sp. group from 7.764 ± 0.040 
to 8.006 ± 0.106 after 48 h incubation (Table III). None-
theless, there was no detectable change in microbial cul-
turing method between the groups of caecal bacteria 
with and without FB1 during the incubation time. 
The quantitative PCR was also performed to deter-
mine the effect of FB1 on total bacteria, Bacteroides and 
Prevotella and Lactobacillus sp. The log10 copy-numbers 
were applied for data analysis (Table IV). The log10 of 
Fig. 2. Hydrolysed fumonisin B1 concentration in experimental
groups during the incubation time.
Aerobic 7.49 ± 0.09 7.58 ± 0.07 7.55 ± 0.15 7.49 ± 0.258 7.26 ± 0.22 7.31 ± 0.19
Anaerobic 9.02 ± 0.05c 9.05 ± 0.04c 8.74 ± 0.19b 8.76 ± 0.05b 8.34 ± 0.08a 8.39 ± 0.14a
E. coli 5.89 ± 0.07 5.87 ± 0.07 5.58 ± 0.11 5.99 ± 0.33 6.16 ± 0.83 5.87 ± 0.66
Coliforms 5.33 ± 0.06 5.39 ± 0.12 5.44 ± 0.11 5.69 ± 0.29 5.99 ± 0.86 5.84 ± 0.55
Lactobacillus 7.76 ± 0.04a 7.87 ± 0.09 7.99 ± 0.06b 8.04 ± 0.09 8.01 ± 0.11b 7.93 ± 0.12
Table III
Number of bacteria in the pigs’ caecal chyme incubated with (experimental group) and without (control 1 group) 
fumonisin B1 measured by culturing (log10 CFU1/g, means ±SD).
1CFU: colony forming unit
a, b, c significant (P < 0.01) difference between incubation times within groups.
Bacteria
Period of the incubation time
0 hour 24 hour 48 hour
Experimental
group Control 1
Experimental
group Control 1
Experimental
group Control 1
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Lactobacillus, Bacteroides and Prevotella in control  1 
and experimental groups augmented after 24 h incu-
bation (P < 0.05). A number of total bacteria was stable 
during the incubation time in the control groups while 
there was an increase in the experimental group from 
11.520 at 0 h to 11.912 at the 24 h incubation. However, 
no significant difference between the control groups 
and the experimental groups in all kinds of investigated 
bacteria was observed. FB1 did not affect the number of 
caecal bacteria in pigs.
As we have detected both in the microbial culture 
and in QPCR experiment during the incubation time, 
the anaerobic bacteria decreased while the amount 
of Lactobacillus sp. increased. According to QPCR 
results the amount of Bacteroides and Prevotella also 
increased. The primary difference between the results 
of two methods is that anaerobic bacteria enumerat-
ing by culture is alive organisms whereas Lactobacil­
lus sp., Bacteroides and Prevotella estimating by QPCR 
based on DNA copy-number. The decline of other, not 
investigated anaerobic bacterial species (i.e. Clostridium 
sp.), might be another reason in this situation. Fur-
ther experiments should be focused on other kinds of 
anaerobic bacteria or all bacterial species using a next 
generation sequencing approach.
To the best of our knowledge, there was is no com-
plete report about the effect of fumonisin on caecal bac-
teria in pigs. Becker et al. (1997) isolated some strains 
of Lactobacillus sp. from pig intestine and determined 
the effect of FB1 (50 and 500 µM) on the growth of these 
strain by turbidometric Bioscreen system. As shown in 
the report, no difference in the growth kinetics between 
the experimental and control groups was observed. 
The DNA of E. coli was not affected by FB1 (Knasmül-
ler et al., 1997) and the number of E. coli showed no 
change in the presence of FB1 in this study. However, 
the intestinal colonisation by pathogenic E. coli in pigs 
treated FB1 was strengthened in an in vivo experiment 
(Oswald et al., 2003). The indirect impact of fumoni-
sin on bacteria was also demonstrated in some docu-
ments; because of immune suppressive effects and 
decrease the specific antibody response of pathogenic 
microorganisms (Taranu et al., 2005; Iheshiulor et al., 
2011), fumonisin can influence activities of colonised 
bacteria in the body such as E. coli and Salmonella sp. 
(Deshmukh et al., 2005; Burel et al., 2013).
Fumonisin B1 was metabolised by pig caecal micro-
organisms. The reduction of FB1 concentration in chyme 
containing groups was sharper than it was in control 
2 group. FB1 concentration decreased while the HFB1 
increased. The amount of screened bacterial species has 
not changed between the groups with and without FB1. 
During the period of incubation, the total number of 
cultured anaerobic bacteria decline while Lactobacillus 
sp. increased. Anaerobic bacteria such as Lactobacillus 
sp., Bacteroides and Prevotella had tended to increase 
revealed by QPCR. FB1 did not impact on the growth 
of investigated bacteria. Other kinds of microorganisms 
should be concerned in the similar experiments and the 
interaction between fumonisins and gut microbiota in 
the in vivo experiments is to be conducted.
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